AGI.do

Products

What will AGI do for Anagestone?

This classification denotes a therapeutic progestin with the molecular formula C22H34O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S8FB38IU3G, chemically known as 17-hydroxy-6.alpha.-methylpregn-4-en-20-one but generally known as anagestone, which bears US NIH Compound Identifier 160650. European Medicines Agency schedules Anagestone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05498MIG. Most nations schedule anagestone under HS 29372300 and SITC 54153. As of Q4 2014, ANAGESTONE remains the US FDA Preferred Term for this commodity. Anagestone bears US NLM identifiers UMLS ID C0051808 and NCI Concept Code C79752. SMILES: CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CCCC4)C.

How AGI delivers it

Four ways AGI delivers for Anagestone

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Anagestone, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Anagestone, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Anagestone connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Melting Pointmodel

Go deeper

Explore Anagestone

Read the deeper take on agi.asView as markdown